Economics of hematopoietic cell transplantation

N Khera, SB Zeliadt, SJ Lee - … Journal of the American Society of …, 2012 - ashpublications.org
Given the rapidly rising healthcare costs, it is important to understand the economic costs of
hematopoietic cell transplantation (HCT), a procedure that is being used more frequently in …

[HTML][HTML] The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, Medicare, and Medicaid

JJ Jacobson, JB Epstein, FC Eichmiller, TB Gibson… - Head & neck …, 2012 - Springer
Background Head and neck cancers are of particular interest to health care providers, their
patients, and those paying for health care services, because they have a high morbidity, they …

An analysis of the distress thermometer problem list and distress in patients with cancer

L VanHoose, LL Black, K Doty, D Sabata… - Supportive care in …, 2015 - Springer
Purpose Patients with a cancer diagnosis experience complex issues that can cause
distress. The purpose of this study is to identify factors associated with overall distress for a …

Support for caregivers of cancer patients: transition after active treatment

BA Given, P Sherwood, CW Given - Cancer epidemiology, biomarkers & …, 2011 - AACR
Family caregivers provide uncompensated care and assistance to a family member who has
cancer. When patients move through the care trajectory into the survivorship phase, roles …

Evolving treatment paradigms for chemotherapy-induced nausea and vomiting

R Wickham - Cancer Control, 2012 - journals.sagepub.com
Background Chemotherapy-induced nausea and vomiting (CINV) is one of the most
debilitating toxicities associated with cancer treatment. Although effective antiemetic agents …

The impact of specialty pharmaceuticals as drivers of health care costs

BR Hirsch, S Balu, KA Schulman - Health Affairs, 2014 - healthaffairs.org
The pharmaceutical industry is shifting its focus from blockbuster small molecules to
specialty pharmaceuticals. Specialty pharmaceuticals are novel drugs and biologic agents …

Employment outcomes among survivors of common cancers: the Symptom Outcomes and Practice Patterns (SOAPP) study

AJ Tevaarwerk, JW Lee, ME Sesto, KA Buhr… - Journal of Cancer …, 2013 - Springer
Introduction Risk factors for employment difficulties after cancer diagnosis are incompletely
understood, and interventions to improve post-cancer employment remain few. New targets …

What does breast cancer treatment cost and what is it worth?

MJ Hassett, EB Elkin - Hematology/Oncology Clinics, 2013 - hemonc.theclinics.com
Breast cancer is the most commonly diagnosed nondermatologic cancer and the second
leading cause of cancer death for women in the United States and, thus, is responsible for …

Benchmarks for value in cancer care: an analysis of a large commercial population

M Kolodziej, JR Hoverman, JS Garey… - Journal of oncology …, 2011 - ascopubs.org
Purpose: Cancer costs are increasing at an unprecedented rate. Key cost drivers include
chemotherapy, hospital admissions/emergency room visits, and aggressive end-of-life care …

Influence of sociodemographic factors on treatment decisions in non–small-cell lung cancer

N Duma, DW Idossa, U Durani, RD Frank, J Paludo… - Clinical lung cancer, 2020 - Elsevier
Introduction In stage IV non–small-cell lung cancer (NSCLC), survival has significantly
improved. Despite such trends, it has been noted that patients frequently refuse treatment …